Atlas Trials

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

Clinical trial NCT04464460 · WITHDRAWN

Trial details

NCT number
NCT04464460
Sponsor
Takeda
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Coronavirus Disease
Start date
2020-09-25
Primary completion
2020-10-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.